Literature DB >> 24829357

Influenza A virus-induced degradation of eukaryotic translation initiation factor 4B contributes to viral replication by suppressing IFITM3 protein expression.

Song Wang1, Xiaojuan Chi2, Haitao Wei1, Yuhai Chen1, Zhilong Chen2, Shile Huang3, Ji-Long Chen4.   

Abstract

UNLABELLED: Although alteration in host cellular translation machinery occurs in virus-infected cells, the role of such alteration and the precise pathogenic processes are not well understood. Influenza A virus (IAV) infection shuts off host cell gene expression at transcriptional and translational levels. Here, we found that the protein level of eukaryotic translation initiation factor 4B (eIF4B), an integral component of the translation initiation apparatus, was dramatically reduced in A549 cells as well as in the lung, spleen, and thymus of mice infected with IAV. The decrease in eIF4B level was attributed to lysosomal degradation of eIF4B, which was induced by viral NS1 protein. Silencing eIF4B expression in A549 cells significantly promoted IAV replication, and conversely, overexpression of eIF4B markedly inhibited the viral replication. Importantly, we observed that eIF4B knockdown transgenic mice were more susceptible to IAV infection, exhibiting faster weight loss, shorter survival time, and more-severe organ damage. Furthermore, we demonstrated that eIF4B regulated the expression of interferon-induced transmembrane protein 3 (IFITM3), a critical protein involved in immune defense against a variety of RNA viruses, including influenza virus. Taken together, our findings reveal that eIF4B plays an important role in host defense against IAV infection at least by regulating the expression of IFITM3, which restricts viral entry and thereby blocks early stages of viral production. These data also indicate that influenza virus has evolved a strategy to overcome host innate immunity by downregulating eIF4B protein. IMPORTANCE: Influenza A virus (IAV) infection stimulates the host innate immune system, in part, by inducing interferons (IFNs). Secreted IFNs activate the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, leading to elevated transcription of a large group of IFN-stimulated genes that have antiviral function. To circumvent the host innate immune response, influenza virus has evolved multiple strategies for suppressing the production of IFNs. Here, we show that IAV infection induces lysosomal degradation of eIF4B protein; and eIF4B inhibits IAV replication by upregulating expression of interferon-induced transmembrane protein 3 (IFITM3), a key protein that protects the host from virus infection. Our finding illustrates a critical role of eIF4B in the host innate immune response and provides novel insights into the complex mechanisms by which influenza virus interacts with its host.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24829357      PMCID: PMC4135930          DOI: 10.1128/JVI.00126-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Role of Itk signalling in the interaction between influenza A virus and T-cells.

Authors:  Kewei Fan; Yinping Jia; Song Wang; Hua Li; Defeng Wu; Guoshun Wang; Ji-Long Chen
Journal:  J Gen Virol       Date:  2012-02-01       Impact factor: 3.891

2.  Transport of influenza virus neuraminidase (NA) to host cell surface is regulated by ARHGAP21 and Cdc42 proteins.

Authors:  Song Wang; Hua Li; Yuhai Chen; Haitao Wei; George F Gao; Hongqiang Liu; Shile Huang; Ji-Long Chen
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

Review 3.  Tinkering with translation: protein synthesis in virus-infected cells.

Authors:  Derek Walsh; Michael B Mathews; Ian Mohr
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-01-01       Impact factor: 10.005

4.  Translational control of the activation of transcription factor NF-κB and production of type I interferon by phosphorylation of the translation factor eIF4E.

Authors:  Barbara Herdy; Maritza Jaramillo; Yuri V Svitkin; Amy B Rosenfeld; Mariko Kobayashi; Derek Walsh; Tommy Alain; Polen Sean; Nathaniel Robichaud; Ivan Topisirovic; Luc Furic; Ryan J O Dowling; Annie Sylvestre; Liwei Rong; Rodney Colina; Mauro Costa-Mattioli; Jörg H Fritz; Martin Olivier; Earl Brown; Ian Mohr; Nahum Sonenberg
Journal:  Nat Immunol       Date:  2012-04-29       Impact factor: 25.606

5.  Phosphorylation of eukaryotic translation initiation factor 4B (EIF4B) by open reading frame 45/p90 ribosomal S6 kinase (ORF45/RSK) signaling axis facilitates protein translation during Kaposi sarcoma-associated herpesvirus (KSHV) lytic replication.

Authors:  Ersheng Kuang; Bishi Fu; Qiming Liang; Jinjong Myoung; Fanxiu Zhu
Journal:  J Biol Chem       Date:  2011-10-12       Impact factor: 5.157

6.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

7.  IFITM3 restricts the morbidity and mortality associated with influenza.

Authors:  Aaron R Everitt; Simon Clare; Thomas Pertel; Sinu P John; Rachael S Wash; Sarah E Smith; Christopher R Chin; Eric M Feeley; Jennifer S Sims; David J Adams; Helen M Wise; Leanne Kane; David Goulding; Paul Digard; Verneri Anttila; J Kenneth Baillie; Tim S Walsh; David A Hume; Aarno Palotie; Yali Xue; Vincenza Colonna; Chris Tyler-Smith; Jake Dunning; Stephen B Gordon; Rosalind L Smyth; Peter J Openshaw; Gordon Dougan; Abraham L Brass; Paul Kellam
Journal:  Nature       Date:  2012-03-25       Impact factor: 49.962

8.  IFITM3 inhibits influenza A virus infection by preventing cytosolic entry.

Authors:  Eric M Feeley; Jennifer S Sims; Sinu P John; Christopher R Chin; Thomas Pertel; Li-Mei Chen; Gaurav D Gaiha; Bethany J Ryan; Ruben O Donis; Stephen J Elledge; Abraham L Brass
Journal:  PLoS Pathog       Date:  2011-10-27       Impact factor: 6.823

9.  Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein.

Authors:  Ricardo Rajsbaum; Randy A Albrecht; May K Wang; Natalya P Maharaj; Gijs A Versteeg; Estanislao Nistal-Villán; Adolfo García-Sastre; Michaela U Gack
Journal:  PLoS Pathog       Date:  2012-11-29       Impact factor: 6.823

Review 10.  Host translation at the nexus of infection and immunity.

Authors:  Ian Mohr; Nahum Sonenberg
Journal:  Cell Host Microbe       Date:  2012-10-18       Impact factor: 21.023

View more
  36 in total

1.  Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.

Authors:  Yongli Xiao; Jae-Keun Park; Stephanie Williams; Mitchell Ramuta; Adriana Cervantes-Medina; Tyler Bristol; Sarah Smith; Lindsay Czajkowski; Alison Han; John C Kash; Matthew J Memoli; Jeffery K Taubenberger
Journal:  Virology       Date:  2019-06-13       Impact factor: 3.616

2.  Influenza A Virus Dysregulates Host Histone Deacetylase 1 That Inhibits Viral Infection in Lung Epithelial Cells.

Authors:  Prashanth Thevkar Nagesh; Matloob Husain
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

3.  Adenovirus-mediated artificial MicroRNAs targeting matrix or nucleoprotein genes protect mice against lethal influenza virus challenge.

Authors:  H Zhang; X Tang; C Zhu; Y Song; J Yin; J Xu; H C J Ertl; D Zhou
Journal:  Gene Ther       Date:  2015-04-23       Impact factor: 5.250

4.  hnRNP K Is a Novel Internal Ribosomal Entry Site-Transacting Factor That Negatively Regulates Foot-and-Mouth Disease Virus Translation and Replication and Is Antagonized by Viral 3C Protease.

Authors:  Wenming Liu; Decheng Yang; Chao Sun; Haiwei Wang; Bo Zhao; Guohui Zhou; Li Yu
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

5.  Interaction of NS2 with AIMP2 facilitates the switch from ubiquitination to SUMOylation of M1 in influenza A virus-infected cells.

Authors:  Shijuan Gao; Jiaoxiang Wu; Ran-Yi Liu; Jiandong Li; Liping Song; Yan Teng; Chunjie Sheng; Dong Liu; Chen Yao; Huiming Chen; Wei Jiang; Shuai Chen; Wenlin Huang
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

6.  Molecular alterations in human milk in simulated maternal nasal mucosal infection with live attenuated influenza vaccination.

Authors:  Pia S Pannaraj; André Guilherme da Costa-Martins; Chiara Cerini; Fan Li; Sook-San Wong; Youvika Singh; Alysson H Urbanski; Patrícia Gonzalez-Dias; Juliana Yang; Richard J Webby; Helder I Nakaya; Grace M Aldrovandi
Journal:  Mucosal Immunol       Date:  2022-06-23       Impact factor: 8.701

7.  The humanized DRAGA mouse (HLA-A2. HLA-DR4. RAG1 KO. IL-2R g c KO. NOD) establishes inducible and transmissible models for influenza type A infections.

Authors:  Mirian Mendoza; Devi Gunasekera; Kathleen P Pratt; Qi Qiu; Sofia Casares; Teodor-D Brumeanu
Journal:  Hum Vaccin Immunother       Date:  2020-03-04       Impact factor: 3.452

Review 8.  Host Cell Restriction Factors of Bunyaviruses and Viral Countermeasures.

Authors:  Solène Lerolle; Natalia Freitas; François-Loïc Cosset; Vincent Legros
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

9.  Influenza A virus NS1 induces degradation of sphingosine 1-phosphate lyase to obstruct the host innate immune response.

Authors:  Jennifer J Wolf; Chuan Xia; Caleb J Studstill; Hanh Ngo; Steven L Brody; Paul E Anderson; Bumsuk Hahm
Journal:  Virology       Date:  2021-03-13       Impact factor: 3.513

Review 10.  Induction of innate immunity and its perturbation by influenza viruses.

Authors:  Mohsan Ullah Goraya; Song Wang; Muhammad Munir; Ji-Long Chen
Journal:  Protein Cell       Date:  2015-07-24       Impact factor: 14.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.